RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SEBASTIANI M
Collezione AO Ordine Mauriziano

Items : 4

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course. in Journal of clinical medicine / J Clin Med. 2019 Nov 18;8(11):2013. doi: 10.3390/jcm8112013.

2019
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Castañeda S; Selva-O'Callaghan A; Matucci-Cerinic M; Triantafyllias K; Lopez-Mejias R; Vicente E; Zampogna G; Gonzalez Perez MI; Mejia M; Bellando Randone S; Gerli R; Bartoloni E; Quartuccio L; Fornaro M; Franceschini F; Iannone F; Schett G; Knitza J; Distler J; Claudia L; Pozzi MR; Dei G; Pesci A; Locatelli F; Marchioni E; Caporali R; Cifrian J; Salaffi F; Giorgi R; et alii...

Timing of onset affects arthritis presentation pattern in antisyntethase syndrome. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2018 Jan-Feb;36(1):44-49. Epub 2017 Jul 26.

2018
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rodriguez Cambrón AB; Castañeda S; Olivieri I; Blázquez Cañamero MÁ; Alpini C; Pereira da Silva JA; Cifrian J; Matos-Costa CJ; Lopez-Mejias R; Gerzeli S; Perez-Gomez N; Mera-Valera A; Pipitone N; Bonella F; Tomietto P; Nuno L; Dei G; Confalonieri M; Pesci A; Marchioni E; Meloni F; Salaffi F; Selmi C; Parisi S; Bravi E; Specker C; Bartoloni Bocci E; Gerli R; Batticciotto A; et alii...

Comparison of efficacy of first- versus second-line adalimumab in patients with rheumatoid arthritis: experience of the Italian biologics registries. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2017 Jul-Aug;35(4):660-665. Epub 2017 May 8.

2017
AO Ordine Mauriziano

Codullo V; Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G; Caporali R;

Drug survival of adalimumab in patients with rheumatoid arthritis over 10 years in the real-world settings: high rate remission together with normal function ability. in Clinical rheumatology / Clin Rheumatol. 2016 Nov;35(11):2649-2656. doi: 10.1007/s10067-016-3349-z. Epub 2016 Jul 14.

2016
AO Ordine Mauriziano

Iannone F; Sinigaglia L; Favalli EG; Sarzi-Puttini P; Atzeni F; Caporali R; Codullo V; Ferraccioli G; Gremese E; Carletto A; Giollo A; Govoni M; Bergossi F; Galeazzi M; Cantarini L; Salaffi F; Di Carlo M; Bazzani C; Pellerito R; Sebastiani M; Ramonda R; Lapadula G;